The blood glucose level at admission indicates (with some limitations) poor prognosis and thrombus burden in patients with the acute coronary syndrome (ACS). Our study aimed to measure the predictive value of the stress hyperglycemia ratio (SHR), an indicator of stress hyperglycemia, showing increased thrombus burden in patients with ACS. Patients (n = 1222) with ACS were enrolled in this cross-sectional study. Coronary thrombus burden was classified as high and low. SHR was calculated by dividing the admission serum glucose by the estimated average glucose derived from HbA1c. Low thrombus burden was detected in 771 patients, while high thrombus burden (HTB) was detected in 451 patients. SHR was found to be significantly higher in patients with HTB (1.1 ± .3 vs 1.06 ± .4; P = .002). SHR was determined as a predictor of HTB (odds ratio (OR) 1.547 95% CI (1.139–2.100), P < .001) as a result of univariate analysis. According to multivariate analysis, SHR was determined as an independent risk factor for HTB (OR 1.328 CI (1.082–1.752), P = .001). We found that SHR predicted thrombus burden with higher sensitivity than admission glucose level in patients with ACS.
IbanezBJamesSAgewallSESC Scientific Document Group, et al.2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119-177.
2.
ScarparoPvan GamerenMWilschutJ, et al.Impact of large thrombus burden on very long-term clinical outcomes in patients presenting with ST-segment elevation myocardial infarction. J Invasive Cardiol. 2021;33:E900-E909.
3.
MatosLCVCarvalhoLSModoloR, et al.Gensini score and thrombus burden add predictive value to the SYNTAX score in detecting no-reflow after myocardial infarction. Arq Bras Cardiol. 2021;116:466-472.
4.
SianosGPapafaklisMIDaemenJ, et al.Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden. J Am Coll Cardiol. 2007;50:573-583.
5.
FukudaDTanakaAShimadaKNishidaYKawarabayashiTYoshikawaJ. Predicting angiographic distal embolization following percutaneous coronary intervention in patients with acute myocardial infarction. Am J Cardiol. 2003;91:403-407.
6.
ScarparoPvan GamerenMWilschutJ, et al.Impact of thrombus burden on long-term clinical outcomes in patients with either anterior or non-anterior ST-segment elevation myocardial infarction. J Thromb Thrombolysis. 2021:54:47-57.
7.
QaseemAHumphreyLLChouRSnowVShekelleP.Clinical Guidelines Committee of the American College of Physicians. Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2011;154:260-267.
8.
Dizdarević-HudićLKusljugićZBarakovićFHajderMHudićI. Do growth hormone and insulin-like growth factor 1 affect prognosis in patients with killip I and II class acute myocardial infarction?Acta Clin Croat. 2016;55:345-353.
9.
CapesSEHuntDMalmbergKGersteinHC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773-778.
10.
WahabNNCowdenEAPearceNJGardnerMJMerryHCoxJLICONS Investigators. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era?J Am Coll Cardiol. 2002;40:1748-1754.
11.
D’OnofrioNSarduCPaolissoP, et al.MicroRNA-33 and SIRT1 influence the coronary thrombus burden in hyperglycemic STEMI patients. J Cell Physiol. 2020; 235: 1438–1452.
12.
SigirciSYildizSSKeskinK, et al.The predictive value of stress hyperglycemia on thrombus burden in nondiabetic patients with st-segment elevation myocardial infarction. Blood Coagul Fibrinolysis. 2019;30:270-276.
13.
IshiharaMKagawaEInoueI, et al.Impact of admission hyperglycemia and diabetes mellitus on short-and long-term mortality after acute myocardial infarction in the coronary intervention era. Am J Cardiol. 2007;99:1674-1679.
14.
RobertsGWQuinnSJValentineN, et al.Relative hyperglycemia, a marker of critical illness: introducing the stress hyperglycemia ratio. J Clin Endocrinol Metab. 2015;100:4490-4497.
15.
ChuJTangJLaiY, et al.Association of stress hyperglycemia ratio with intracoronary thrombus burden in diabetic patients with ST-segment elevation myocardial infarction. J Thorac Dis. 2020;12:6598-6608.
16.
CuiKFuRYangJ, et al.Stress hyperglycemia ratio and long-term mortality after acute myocardial infarction in patients with and without diabetes: a prospective, nationwide, and multicentre registry. Diabetes Metab Res Rev. 2022;38:e3562.
17.
SchmitzTFreuerDHarmelE, et al.Prognostic value of stress hyperglycemia ratio on short-and long-term mortality after acute myocardial infarction. Acta Diabetol. 2022:59:1019-1029.
18.
RoffiMPatronoCColletJ-P, et al.2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Kardiol Pol. 2015;73:1207-1294.
19.
NathanDMKuenenJBorgRZhengHSchoenfeldDHeineRJA1c-Derived Average Glucose Study Group. Translating the A1C assay into estimated average glucose values. Diabetes Care. 2008;31:1473-1478.
20.
FirmanDAlkatiriAATaslimIWangiSBPranataR. Effect of thrombus aspiration on microcirculatory resistance and ventricular function in patients with high thrombus burden. BMC Cardiovasc Disord. 2020;20:153-156.
21.
TimmerJRHoekstraMNijstenMWN, et al.Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment–elevation myocardial infarction treated with percutaneous coronary intervention. Circulation. 2011;124:704-711.
22.
SudicDRazmaraMForslundMJiQHjemdahlPLiN. High glucose levels enhance platelet activation: involvement of multiple mechanisms. Br J Haematol. 2006;133:315-322.
23.
RauchUCrandallJOsendeJI, et al.Increased thrombus formation relates to ambient blood glucose and leukocyte count in diabetes mellitus type 2. Am J Cardiol. 2000;86:246-249.
24.
DunnEJAriënsRASGrantPJ. The influence of type 2 diabetes on fibrin structure and function. Diabetologia. 2005;48:1198-1206.
25.
DunnEJPhilippouHAriënsRASGrantPJ. Molecular mechanisms involved in the resistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitus. Diabetologia. 2006;49:1071-1080.
26.
ColletJPParkDLestyC, et al.Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy. Arterioscler Thromb Vasc Biol. 2000;20:1354-1361.
27.
HoodJEYesudasanSAverettRD. Glucose concentration affects fibrin clot structure and morphology as evidenced by fluorescence imaging and molecular simulations. Clin Appl Thromb Hemost. 2018;24:104S-116S.
28.
SarduCBarbieriMBalestrieriML, et al.Thrombus aspiration in hyperglycemic ST-elevation myocardial infarction (STEMI) patients: clinical outcomes at 1-year follow-up. Cardiovasc Diabetol. 2018;17(1):1-16.
29.
TopalDMutluerFOAydinO, et al.The relationship between hemoglobin A1c levels and thrombus load in patients with type 2 diabetes mellitus and non-ST-segment elevation myocardial infarction. J Res Med Sci. 2021;26:118-118.
30.
GalvaniMFerriniDOttaniF. Natriuretic peptides for risk stratification of patients with acute coronary syndromes. Eur J Heart Fail. 2004;6:327-333.
31.
BagaiAHuangZLokhnyginaY, et al.Magnitude of troponin elevation and long-term clinical outcomes in acute coronary syndrome patients treated with and without revascularization. Circ Cardiovasc Interv. 2015;8:e002314.
32.
BraithwaiteSS. Through the eyes of the A1C: a call to re-examine stress hyperglycemia. Crit Care Med. 2010;38:717-719.
PlanerDWitzenbichlerBGuagliumiG, et al.Impact of hyperglycemia in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: the HORIZONS-AMI trial. Int J Cardiol. 2013;167:2572-2579.
35.
PinheiroCPOliveiraMDPFaroGBA, et al.Prognostic value of stress hyperglycemia for in-hospital outcome in acute coronary artery disease. Arq Bras Cardiol. 2013;100:127-134.
36.
ModenesiRFPenaFMFariaCAC, et al.Prevalência e influência da hiperglicemia de estresse no prognóstico em uma coorte de pacientes com síndrome coronariana aguda. Rev bras ter intensiva. 2012;24:352-356.
37.
DeedwaniaPKosiborodMBarrettE, et al.Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2008;117:1610-1619.
38.
EgiMBellomoRStachowskiE, et al.The interaction of chronic and acute glycemia with mortality in critically ill patients with diabetes. Crit Care Med. 2011;39:105-111.
39.
EgiMBellomoRStachowskiE, et al.Blood glucose concentration and outcome of critical illness: the impact of diabetes. Crit Care Med. 2008;36:2249-2255.
